1. Academic Validation
  2. Noonan syndrome

Noonan syndrome

  • Lancet. 2013 Jan 26;381(9863):333-42. doi: 10.1016/S0140-6736(12)61023-X.
Amy E Roberts 1 Judith E Allanson Marco Tartaglia Bruce D Gelb
Affiliations

Affiliation

  • 1 Department of Cardiology and Division of Genetics, Children's Hospital Boston, Boston, MA 02115, USA. [email protected]
Abstract

Noonan syndrome is a genetic multisystem disorder characterised by distinctive facial features, developmental delay, learning difficulties, short stature, congenital heart disease, renal anomalies, lymphatic malformations, and bleeding difficulties. Mutations that cause Noonan syndrome alter genes encoding proteins with roles in the RAS-MAPK pathway, leading to pathway dysregulation. Management guidelines have been developed. Several clinically relevant genotype-phenotype correlations aid risk assessment and patient management. Increased understanding of the pathophysiology of the disease could help development of pharmacogenetic treatments.

Figures